Glucose Health Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Murray Fleming
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 10.1yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2022 | n/a | n/a | -US$357k |
| Jun 30 2022 | n/a | n/a | -US$497k |
| Mar 31 2022 | n/a | n/a | -US$543k |
| Dec 31 2021 | US$24k | US$24k | -US$339k |
Compensation vs Market: Insufficient data to establish whether Murray's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Murray's compensation with company performance.
CEO
Murray Fleming (61 yo)
10.1yrs
Tenure
US$84,000
Compensation
Mr. Murray S. Fleming has been the Chief Executive Officer of Glucose Health, Inc. since October 01, 2014 and its Chief Financial Officer since February 10, 2015. Mr. Fleming serves as Controller of Nacel...